<DOC>
	<DOCNO>NCT01628081</DOCNO>
	<brief_summary>This double blind , parallel group , randomize study 12 week daily oral administration Dunaliella placebo psoriasis patient .</brief_summary>
	<brief_title>The Effect Alga Dunaliella Bardawil Psoriasis</brief_title>
	<detailed_description>Subjects screen eligibility baseline visit blood test . After screen phase maximum two week subject randomized one two treatment group ( 1:1 ) : Dunaliella placebo . Each subject final evaluation 4 week end study drug treatment .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Male female subject , ≥ 18 ≤ 75 year age , diagnosis plaque guttate psoriasis ; Psoriasis cover ≤ 20 % body surface area ( BSA ) Have least 2 psoriatic plaque measure 3 cm . For female subject ; either : subject nonchildbearing potential , define : menopause amenorrhea &gt; 2 year , hysterectomy , bilateral oophorectomy agrees continue use adequate contraception ( i.e. , hormonal [ oral , depot , patch ] , IUD , barrier spermicide ) throughout study least one month follow termination negative urinary pregnancy test screen first dose study drug ; In opinion Investigator , subject compliant high probability complete study require procedure . The subject present predominant type psoriasis erythrodermic , inverse , pustular palmoplantar unstable form psoriasis ; Received investigational drug within 30 day randomization . The subject use follow psoriasis treatment elaborate period , prior date screen visit : Topical psoriasis treatment , exclude emollient 2week period Any systemic psoriasis treatment include biologic treatment 4week 5half life time period ( whichever longer ) Phototherapy Climatotherapy 4week period The subject know allergy sensitivity study treatment ( ) percipient contain study drug formulation Any acute chronic medical condition , opinion Investigator , increase risk subject likelihood subject unable complete study ; Subjects laboratory test screening consider significantly abnormal . The following consider significantly abnormal : Alanine transaminase ( ALT ) , aspartate transaminase ( AST ) &gt; 3 upper limit normal . CPK &gt; 3 upper limit normal . Triglycerides &gt; 350mg/dl . cytopenia ( include follow : WBC &lt; 35000/μL ; Hgb &lt; 10 g/dL ; platelet &lt; 120,000/μL ; neutrophil absolute &lt; 1500/μL lymphocyte absolute &lt; 800/μL ) Known serologic positively human immunodeficiency virus hepatitis B hepatitis C virus . History substance abuse , include alcohol abuse , within past year . History current clinically significant major psychiatric disorder ( e.g. , major depressive disorder , psychosis , schizophrenia ) accord criterion Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSM IV TR ) [ Exception ; subject depression adequately control least 6 month may enroll study ] ; Female subject positive pregnancy test nursing , plan pregnancy course study ; Unwilling unable comply study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>psoriasis</keyword>
	<keyword>Alga Dunaliella Bardawil</keyword>
</DOC>